Tata CRISPR Covid-19 test gets regulatory approval for commercial use
(WorldNews Business)

The Tata CRISPR test, powered by CSIR-IGIB FELUDA, has received regulatory approvals from the Drug Controller General of India (DCGI) for commercial launch, meeting the quality benchmarks with 96 per cent sensitivity and 98 per cent specificity for detecting the novel coronavirus, a note from the Tata Group said. This test uses an indigenously developed...